GO:0060426 lung vasculature development: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060426 lung vasculature development describes the progression of the lung vasculature from its initial formation to a mature structure, comprising the tubule structures that carry blood or lymph in the lungs.
• The process begins early in fetal life and involves coordinated angiogenesis, vasculogenesis, and remodeling of pulmonary vessels.
• Key molecular regulators include vascular endothelial growth factor (VEGF), bone morphogenetic protein 9 (BMP9), retinoic acid, and a network of transcription factors such as Foxf1, Tbx4, and Sox17.
• Disruption of lung vasculature development is linked to bronchopulmonary dysplasia, pulmonary hypertension, and lung cancer progression.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect gene function in pulmonary vascular development.
• Understanding this process informs regenerative medicine, disease modeling, and therapeutic targeting of pulmonary vascular disorders.
Description
Lung vasculature development (GO:0060426) is the biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure, which is composed of the tubule structures that carry blood or lymph in the lungs. The pulmonary vasculature is essential for gas exchange, and its proper development is critical for neonatal survival and long-term respiratory health. Research over the past decades has revealed that lung vasculature development is not a simple sprouting process but a complex, multi-step program involving vasculogenesis, angiogenesis, and remodeling, tightly regulated by signaling pathways and transcription factors. Defects in this process contribute to a range of human diseases, including bronchopulmonary dysplasia, pulmonary arterial hypertension, and lung cancer. Therefore, understanding the molecular and cellular mechanisms of lung vasculature development is of paramount importance for both developmental biology and clinical translation.
lung vasculature development At A Glance
| GO ID | GO:0060426 |
|---|---|
| GO term | lung vasculature development |
| Ontology | biological_process |
| Synonym | pulmonary vasculature development |
| Major function | Formation and maturation of the blood and lymphatic vessel network in the lungs |
| Key regulators | VEGF, BMP9, retinoic acid, transcription factors (Foxf1, Tbx4, Sox17, etc.) |
| Associated diseases | Bronchopulmonary dysplasia, pulmonary hypertension, lung cancer |
| Research methods | Lineage tracing, knockout mice, CRISPR editing, imaging, transcriptomics |
What Is GO:0060426?
According to the Gene Ontology, GO:0060426 lung vasculature development is defined as the biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs. In simpler terms, it encompasses all the events that build and shape the blood and lymphatic vessel network of the lungs, from the earliest progenitor cells to the fully functional mature vessels.
Why Is lung vasculature development Important in Cell Biology?
Lung vasculature development is fundamental to respiratory physiology because the pulmonary vasculature is the site of gas exchange. Without a properly formed and remodeled vascular network, oxygen uptake and carbon dioxide removal are compromised, leading to neonatal respiratory failure and chronic lung disease. Moreover, the lung vasculature is not merely a passive conduit; it actively signals to the developing lung epithelium and mesenchyme, influencing branching morphogenesis and alveolarization. Dysregulation of this process is a hallmark of several devastating diseases, including bronchopulmonary dysplasia in preterm infants, pulmonary arterial hypertension, and tumor angiogenesis in lung cancer. Thus, deciphering the mechanisms of lung vasculature development has direct implications for understanding disease pathogenesis and for developing targeted therapies.
• Essential for gas exchange and neonatal survival.
• Coordinates with lung epithelial branching morphogenesis.
• Dysregulated in bronchopulmonary dysplasia and pulmonary hypertension.
• Involved in tumor angiogenesis and cancer progression.
• Provides a model for studying organ-specific vascular heterogeneity.
• Informs regenerative strategies for lung repair.
• Key to understanding genetic syndromes with pulmonary vascular defects.
• Serves as a paradigm for developmental angiogenesis.
• Offers targets for anti-angiogenic or pro-angiogenic therapies.
• Requires precise spatiotemporal regulation by multiple signaling pathways.
What Happens During lung vasculature development?
Initiation and Vasculogenesis
In simple terms: The first blood vessels in the lung are formed from precursor cells that assemble into primitive tubes.
Lung vasculature development begins early in fetal life with the formation of the primary vascular plexus. In humans, the earliest pulmonary vessels can be observed around 5 weeks of gestation, arising from angiogenic sprouts and possibly from vasculogenic progenitors. This initial phase involves the differentiation of endothelial cells and their organization into a primitive capillary network. The process is driven by signaling molecules such as vascular endothelial growth factor (VEGF), which promotes endothelial cell proliferation and migration. Disruption of VEGF signaling leads to severe vascular defects and impaired lung development.
Angiogenesis and Sprouting
In simple terms: New blood vessels sprout from existing ones to expand the network.
Following the initial plexus, angiogenesis expands the vascular network through sprouting and intussusception. This phase is characterized by endothelial cell sprouting, guided by tip cells and stalk cells, and is regulated by VEGF, Notch, and angiopoietin signaling. The developing lung vasculature must keep pace with the growing lung epithelium, and reciprocal signaling between endothelial cells and epithelial cells is essential for coordinated growth. Bone morphogenetic protein 9 (BMP9) has been identified as a critical regulator of pulmonary vascular growth and remodeling, acting through ALK1 and BMPR2 receptors.
Remodeling and Maturation
In simple terms: The primitive vessel network is refined into a mature, hierarchical vascular tree.
As development proceeds, the pulmonary vascular bed undergoes extensive remodeling, including pruning of excess vessels, stabilization of mature vessels by pericyte coverage, and formation of distinct arterial, venous, and capillary compartments. This maturation phase involves the recruitment of mural cells and the deposition of extracellular matrix. Transcription factors such as Foxf1, Tbx4, and Sox17 play key roles in specifying arterial and venous identity and in maintaining vascular integrity. Retinoic acid signaling is also crucial for alveolarization and vascular maturation.
Lymphatic Vascular Development
In simple terms: Lymphatic vessels, which drain fluid from the lungs, also develop alongside blood vessels.
The lung vasculature includes lymphatic vessels, which develop later than blood vessels and are essential for fluid homeostasis and immune surveillance. Lymphatic endothelial cells arise from venous progenitors and migrate into the lung mesenchyme, guided by signals such as VEGF-C and VEGF-D. Although less studied than blood vessels, lymphatic development in the lung is critical for normal lung function, and its disruption can lead to lymphedema and impaired immune responses.
Integration with Alveolarization
In simple terms: Blood vessels grow in close coordination with the formation of air sacs (alveoli).
Late in lung development, the vascular network expands in parallel with alveolarization, the process that creates the gas-exchange surface. This coordinated growth ensures that each alveolus is surrounded by a dense capillary network. Signaling between endothelial cells and alveolar epithelial cells, mediated by factors such as VEGF and BMP9, is essential for this integration. Disruption of this coordination leads to simplified alveoli and reduced vascular density, as seen in bronchopulmonary dysplasia.
Key Genes Involved in GO:0060426 lung vasculature development
The following genes and proteins have been experimentally implicated in lung vasculature development, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGF | Promotes endothelial cell proliferation, migration, and survival | Knockout causes lethal vascular defects; key target in lung angiogenesis |
| BMP9 | Regulates pulmonary vascular growth and remodeling via ALK1/BMPR2 | Linked to pulmonary hypertension; knockout models show vascular abnormalities |
| Foxf1 | Transcription factor required for pulmonary vascular development | Haploinsufficiency leads to alveolar capillary dysplasia |
| Tbx4 | Transcription factor specifying pulmonary vascular identity | Mutations associated with lung vascular malformations |
| Sox17 | Regulates endothelial differentiation and arterial identity | Important for vascular patterning in the lung |
| Retinoic acid signaling | Promotes alveolarization and vascular maturation | Vitamin A deficiency impairs lung vascular development |
| Notch receptors | Regulate endothelial tip/stalk cell selection during sprouting | Modulate vascular density and patterning |
| Angiopoietin-1/2 | Stabilize vessels and regulate quiescence | Influence vascular remodeling and permeability |
| VEGFR2 | Primary receptor for VEGF signaling in endothelial cells | Essential for vasculogenesis and angiogenesis |
| BMPR2 | Receptor for BMP9; mutations cause pulmonary arterial hypertension | Key disease gene; models for PAH |
| ALK1 | Endothelial BMP receptor | Mutations linked to hereditary hemorrhagic telangiectasia |
| VEGF-C | Lymphatic endothelial growth factor | Regulates lymphatic development in the lung |
| Prox1 | Lymphatic endothelial transcription factor | Required for lymphatic vessel formation |
| Hey1/Hey2 | Notch target genes in endothelium | Modulate arterial-venous specification |
| COUP-TFII | Regulates venous identity | Knockout leads to abnormal vascular patterning |
| Wnt/β-catenin | Signaling pathway in vascular development | Influences endothelial proliferation and differentiation |
How Is lung vasculature development Regulated?
Lung vasculature development is regulated by a complex interplay of signaling pathways, transcription factors, and epigenetic modifiers. Key pathways include VEGF, BMP9/ALK1/BMPR2, Notch, angiopoietin/Tie2, and retinoic acid signaling. Transcription factors such as Foxf1, Tbx4, Sox17, and COUP-TFII orchestrate gene expression programs that specify arterial, venous, and lymphatic identities. Additionally, hypoxia-inducible factors (HIFs) sense oxygen levels and modulate VEGF expression, linking vascular development to metabolic cues. The process is also influenced by mechanical forces, such as blood flow and shear stress, which activate mechanosensitive pathways. Dysregulation of these regulatory networks can lead to vascular malformations and disease.
lung vasculature development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BMP9 | Pulmonary arterial hypertension; impaired vascular remodeling | Endothelial-specific knockout mouse; CRISPR point mutation of Bmp9 |
| VEGF | Bronchopulmonary dysplasia; disrupted angiogenesis | Conditional knockout in lung epithelium; overexpression models |
| Foxf1 | Alveolar capillary dysplasia with misalignment of pulmonary veins | Haploinsufficient mouse; knock-in of patient mutations |
| BMPR2 | Heritable pulmonary arterial hypertension | Endothelial-specific knockout; knock-in of patient mutations |
| Notch receptors | Vascular malformations; tumor angiogenesis | Inducible endothelial knockout; overexpression of constitutively active Notch |
Bronchopulmonary Dysplasia (BPD)
Bronchopulmonary dysplasia is a chronic lung disease of preterm infants characterized by impaired alveolarization and dysmorphic pulmonary vasculature. Disruption of lung vasculature development, particularly reduced VEGF signaling and BMP9 deficiency, contributes to the simplified alveolar and vascular phenotype seen in BPD. Experimental models with conditional knockout of VEGF or BMP9 in the lung endothelium recapitulate key features of BPD, making them valuable for studying disease mechanisms and testing therapies.
Pulmonary Arterial Hypertension (PAH)
Pulmonary arterial hypertension is a progressive disorder characterized by increased pulmonary vascular resistance and remodeling of small pulmonary arteries. Mutations in BMPR2, a receptor for BMP9, are the most common genetic cause of heritable PAH, and impaired BMP9 signaling leads to endothelial dysfunction and vascular remodeling. Animal models with endothelial-specific deletion of Bmpr2 or Bmp9 develop features of PAH, providing insights into disease pathogenesis and potential therapeutic targets.
Lung Cancer and Tumor Angiogenesis
Lung cancer is characterized by uncontrolled angiogenesis, and tumor vessels often exhibit abnormal structure and function. The molecular pathways that drive developmental lung vasculature, such as VEGF and Notch, are frequently hijacked by tumors to promote growth and metastasis. Vascular normalization strategies aim to restore a more normal vascular phenotype to improve drug delivery and immune cell infiltration. Understanding developmental vascular signaling can inform anti-angiogenic therapies and identify resistance mechanisms.
From lung vasculature development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial sprouting in the lung? | Endothelial-specific knockout (e.g., Cdh5-Cre; X fl/fl) |
| Does a point mutation in gene Y cause pulmonary hypertension? | Knock-in mouse carrying the patient mutation |
| Can overexpression of gene Z rescue vascular defects? | Endothelial-specific overexpression (e.g., ROSA26-LSL-Z) |
| What is the spatiotemporal expression of gene W during lung development? | Tagged knock-in (e.g., GFP or LacZ reporter) |
| Which genes are essential for lymphatic development in the lung? | Lymphatic-specific knockout (e.g., Prox1-CreER; X fl/fl) |
| How does gene V affect alveolarization and vascular density? | Inducible knockout in alveolar epithelium or endothelium |
How to Study the lung vasculature development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and origin of vascular cells | Identifying endothelial progenitors in lung development |
| Single-cell RNA-seq | Gene expression heterogeneity at single-cell level | Discovering novel endothelial subtypes and regulators |
| Conditional knockout mice | Gene function in specific cell lineages | Testing the role of Bmp9 in pulmonary vascular remodeling |
| CRISPR-Cas9 knockout | Loss-of-function phenotypes in vitro and in vivo | Validating candidate genes from screens |
| Immunofluorescence | Protein localization and vascular morphology | Visualizing capillary networks in developing lung |
| Western blot | Protein expression and signaling activation | Assessing VEGF or BMP9 pathway activity |
| Tube formation assay | Angiogenic capacity of endothelial cells | Screening pro- or anti-angiogenic factors |
| Micro-CT angiography | 3D vascular architecture in whole lungs | Quantifying vascular density in disease models |
Lineage Tracing and Imaging
Lineage tracing using Cre-loxP systems allows researchers to follow the fate of endothelial progenitors during lung vasculature development. Confocal and light-sheet microscopy of whole-mount lungs stained with endothelial markers (e.g., CD31, VEGFR2) provide three-dimensional views of vascular patterning. These methods have revealed that the pulmonary vasculature arises from both angiogenic sprouting and vasculogenic progenitors.
Transcriptomics and Single-Cell RNA Sequencing
Bulk and single-cell RNA sequencing (scRNA-seq) of developing lung tissue can identify gene expression programs and cell types involved in vascular development. scRNA-seq has uncovered heterogeneity among endothelial cells and revealed novel regulators of angiogenesis. Comparative transcriptomics between wild-type and mutant lungs can pinpoint pathways disrupted in disease models.
Genetic Mouse Models
Conditional knockout and knock-in mice are indispensable for studying gene function in lung vasculature development. Endothelial-specific Cre drivers (e.g., Cdh5-Cre, Tie2-Cre) enable targeted deletion of genes such as Bmp9, Vegfa, or Bmpr2. These models have provided critical insights into the role of specific genes in vascular morphogenesis and disease.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 technology allows precise editing of the genome in cell lines and animal models. It can be used to generate knockout, point mutations, knock-in reporters, and overexpression constructs. In the context of lung vasculature development, CRISPR screens can identify novel regulators of endothelial cell proliferation, migration, and tube formation. This approach accelerates functional validation of candidate genes identified by genomics.
How CRISPR Can Be Used to Study GO:0060426 lung vasculature development
Knockout
CRISPR knockout (KO) is used to completely ablate a gene of interest to study its role in lung vasculature development. For example, endothelial-specific KO of Bmp9 in mice leads to impaired pulmonary vascular growth and remodeling, mimicking aspects of pulmonary hypertension. KO models are essential for distinguishing whether a gene is required for initiation, sprouting, or maturation of the pulmonary vasculature.
Point Mutation
CRISPR point mutation introduces specific nucleotide changes to model human disease-associated variants. For instance, knock-in of a BMPR2 mutation found in heritable PAH can recapitulate the disease phenotype in mice, allowing researchers to study the molecular mechanisms and test targeted therapies. Point mutations are also useful for dissecting phosphorylation sites or binding interfaces in signaling proteins.
Knock-in
CRISPR knock-in can insert reporter genes (e.g., GFP, LacZ) or epitope tags into endogenous loci to track gene expression and protein localization. Tagged knock-in of endothelial markers such as CD31 or VEGFR2 enables precise visualization of vascular development in real time. Knock-in of Cre recombinase under a specific promoter (e.g., Cdh5-Cre) facilitates lineage tracing and conditional mutagenesis.
Overexpression
CRISPR activation (CRISPRa) or knock-in of a strong promoter can drive overexpression of a gene of interest. Overexpression of VEGF in the developing lung epithelium leads to increased vascular density and altered branching morphogenesis, demonstrating the importance of dosage-sensitive signaling. Overexpression models are valuable for testing sufficiency and for identifying downstream effectors.
How EDITGENE Supports lung vasculature development Research
Researchers studying lung vasculature development-related genes often need to determine whether a candidate gene is causally involved in vascular morphogenesis, remodeling, or disease. Generating precise genetic models is a critical step in this process, and CRISPR-based editing offers unparalleled flexibility and efficiency. EDITGENE provides a comprehensive suite of services to support these investigations, from knockout and point mutation to knock-in and overexpression, as well as library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for lung vasculature development research.
Frequently Asked Questions About lung vasculature development
What is GO:0060426 lung vasculature development?
GO:0060426 is a Gene Ontology biological process term defined as the progression of a lung vasculature from an initial condition to its mature state, beginning with the formation of the lung vasculature and ending with the mature structure composed of tubule structures that carry blood or lymph in the lungs.
What genes are involved in lung vasculature development?
Key genes include VEGF, BMP9, BMPR2, ALK1, Foxf1, Tbx4, Sox17, Notch receptors, angiopoietins, and retinoic acid signaling components, as identified in developmental and genetic studies.
Why is lung vasculature development important?
It is essential for gas exchange and neonatal survival, and its disruption contributes to bronchopulmonary dysplasia, pulmonary hypertension, and lung cancer.
What are the main stages of lung vasculature development?
The process includes initiation/vasculogenesis, angiogenesis and sprouting, remodeling and maturation, lymphatic development, and integration with alveolarization.
How is lung vasculature development regulated?
It is regulated by signaling pathways such as VEGF, BMP9/ALK1/BMPR2, Notch, angiopoietin/Tie2, and retinoic acid, as well as transcription factors like Foxf1, Tbx4, and Sox17.
What diseases are associated with abnormal lung vasculature development?
Bronchopulmonary dysplasia, pulmonary arterial hypertension, and lung cancer are among the diseases linked to disrupted pulmonary vascular development.
How can CRISPR be used to study lung vasculature development?
CRISPR can generate knockout, point mutation, knock-in, and overexpression models in endothelial cells and mice to dissect gene function in vascular morphogenesis and disease.
What model organisms are used to study lung vasculature development?
Mice are the most common model, with conditional knockout and knock-in alleles allowing endothelial-specific gene manipulation. Zebrafish and cell culture systems are also used.
What methods are used to analyze lung vasculature development?
Methods include lineage tracing, single-cell RNA-seq, immunofluorescence, tube formation assays, and micro-CT angiography.
How does BMP9 signaling affect lung vasculature?
BMP9 controls pulmonary vascular growth and remodeling through ALK1 and BMPR2 receptors; its dysregulation leads to pulmonary hypertension.
Conclusion
Lung vasculature development (GO:0060426) is a complex, multi-stage process essential for respiratory function. It involves the coordinated action of numerous signaling pathways and transcription factors, and its disruption underlies several human diseases. Continued research using advanced genetic models and CRISPR technologies will further unravel the molecular mechanisms and provide new therapeutic opportunities. EDITGENE is committed to supporting this research with high-quality CRISPR services and bioinformatics solutions.
References
- 1. Augustin HG et al.. 2017. Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology.. Science 357(6353) PMID: 28775214
- 2. Zeng J et al.. 2014. [Vascular normalization and cancer immunotherapy].. Zhongguo Fei Ai Za Zhi 17(3):273-6 PMID: 24667268
- 3. deMello DE et al.. 1997. Early fetal development of lung vasculature.. Am J Respir Cell Mol Biol 16(5):568-81 PMID: 9160839
- 4. Fernandes-Silva H et al.. 2020. Retinoic Acid: A Key Regulator of Lung Development.. Biomolecules 10(1) PMID: 31963453
- 5. Bolte C et al.. 2018. Transcription Factors Regulating Embryonic Development of Pulmonary Vasculature.. Adv Anat Embryol Cell Biol 228:1-20 PMID: 29288383
- 6. Roth-Kleiner M et al.. 2003. Genetic control of lung development.. Biol Neonate 84(1):83-8 PMID: 12890942
- 7. Berrebeh N et al.. 2025. Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling.. Proc Natl Acad Sci U S A 122(26):e2410229122 PMID: 40549904
- 8. Zhao L et al.. 2005. Vascular endothelial growth factor co-ordinates proper development of lung epithelium and vasculature.. Mech Dev 122(7-8):877-86 PMID: 15927453
